Lataa...
Inhibition of autophagy flux by sertraline attenuates TRAIL resistance in lung cancer via death receptor 5 upregulation
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potential target for cancer therapy, owing to its ability to selectively kill cancer cells without causing significant toxicity to normal cells. However, due to the lack of death receptor expression, cancer cells can become highly...
Tallennettuna:
| Julkaisussa: | Int J Mol Med |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7307864/ https://ncbi.nlm.nih.gov/pubmed/32626921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2020.4635 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|